Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha

CourtCourt of Appeals of Texas
DecidedApril 22, 2021
Docket09-20-00243-CV
StatusPublished

This text of Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha (Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha, (Tex. Ct. App. 2021).

Opinion

In The

Court of Appeals

Ninth District of Texas at Beaumont

__________________

NO. 09-20-00243-CV __________________

STEWARD MEDICAL GROUP D/B/A PERMIAN PREMIER HEALTH SERVICES AND JOHN LEE, Appellants

V.

MICHELLE ARMSTRONG, INDIVIDUALLY AND AS REPRESENTATIVE OF THE ESTATE OF BOBBY FOSHA, AND PEGGY FOSHA, Appellees __________________________________________________________________

On Appeal from the 136th District Court Jefferson County, Texas Trial Cause No. D-205,748 __________________________________________________________________

MEMORANDUM OPINION

The Texas Medical Liability Act requires trial courts to dismiss lawsuits

alleging a healthcare liability claim unless the plaintiffs, shortly after they file the

suit, serve the defendants with a report that is “an objective good faith effort to

comply” with the expert-report requirements in Chapter 74 of the Act. 1 In this

1 Tex. Civ. Prac. & Rem. Code Ann. § 74.351(l). 1 interlocutory appeal, we must decide whether the trial court abused its discretion by

denying the objections the defendants lodged to the plaintiffs’ Chapter 74 reports

claiming the plaintiffs’ reports did not represent a good faith effort to provide the

reports required by the Act. We conclude that since no abuse of discretion occurred,

the trial court’s order denying the defendants’ motion to dismiss should be affirmed.

Background

Michelle Armstrong (as the executor of the Estate of Bobby Fosha) and Peggy

Fosha (Bobby Fosha’s widow) sued Dr. John Lee and Steward Medical Group under

the Texas Wrongful Death and Survival Act and alleged they negligently caused

Bobby Fosha’s death. 2 According to the Plaintiffs’ Original Petition, Bobby died

from an adverse side reaction to Celexa, an antidepressant prescribed by Dr. Lee

during an office visit on October 23, 2018. In their suit, the plaintiffs alleged that Dr.

Lee failed to warn Bobby about the increased risk of suicide they claimed is

associated with antidepressants like Celexa. They also alleged that several days after

Bobby started taking the medication, Dr. Lee learned from one of Bobby’s family

members that Bobby was confused after starting the Celexa. According to the motion

2 See id. § 71.002(b) (under the Texas Wrongful Death Statute, a person is liable “for damages arising from an injury that causes an individual’s death if the injury was caused by the person’s or his agent’s or servant’s wrongful act, neglect, carelessness, unskillfulness, or default”); id. § 71.021(a) (under the Texas Survival Act, a “cause of action for personal injury to the health, reputation, or person of an injured person does not abate because of the death of the injured person”). 2 to dismiss and the plaintiffs’ response, Celexa comes with warnings, including one

stating: “Patients of all ages who are started on antidepressant therapy should be

monitored appropriately and observed closely for clinical worsening, suicidality, or

unusual changes in behavior.” In the lawsuit, the plaintiffs alleged Dr. Lee

negligently

• failed to prescribe Bobby an appropriate starting dose of Celexa and instead, gave him four times the recommended starting dose under FDA dosing guidelines,

• failed to assess and account for Bobby’s past medical history in prescribing a treatment plan that involved Celexa,

• failed to properly screen Bobby for depression and assess his risk of suicide before prescribing Celexa,

• failed to warn Bobby about the increased risk of suicide associated with Celexa during the office visit and after learning several days later from one of Bobby’s family members that he seemed confused,

• failed to closely monitor Bobby’s Celexa at a reduced dose after being told by a member of Bobby’s family that Bobby was suffering from symptoms Dr. Lee should have recognized as associated with “Celexa- induced delirium[,]” and

• failed to discontinue Bobby’s Celexa and instead instructed Bobby’s family to have Bobby take Celexa at a reduced dose after Dr. Lee learned Bobby appeared manic and confused after he started taking Celexa.

The plaintiffs also alleged the above acts and omissions proximately caused Bobby’s

death.

3 Shortly after filing suit, the plaintiffs served Dr. Lee and Steward Medical

with two reports, signed by doctors, to meet the requirements of Chapter 74. One

report, written by Dr. Michael Dominguez, reflects that he is a board-certified family

physician with experience practicing in the field of family medicine, the same area

of medicine as Dr. Lee. The other report, signed by Dr. Thomas Kosten, reflects that

he is a board-certified psychiatrist and neurologist who has published over 750

papers and books in his field as a psychiatrist, an area that includes the diagnosis and

treatment of anxiety disorders, the risk of suicide associated with such disorders, and

treating these patients who have these disorders with medications like Celexa.

In Dominguez’s report, he criticized Dr. Lee for failing to obtain a complete

medical history after seeing Bobby in his office on October 23, failing to use

screening tools that he claims are required to diagnose and document the severity of

a patient’s anxiety before prescribing an antidepressant, prescribing Celexa at a

higher dose than the one the FDA recommends for patients as old as Bobby, and

failing to instruct Bobby’s daughter to take Bobby to an emergency room after

learning that Bobby had suffered an adverse reaction after he started the Celexa at

the dosage Dr. Lee prescribed. According to Dr. Dominguez, had Dr. Lee not

negligently prescribed the medication at too high a dose and had he monitored

Bobby based on the standard that applies to starting patients on Celexa, Bobby “more

4 likely than not and to a reasonable degree of medical probability” would not have

shot himself and died.

Dr. Kosten’s report also criticizes Dr. Lee for (1) giving Bobby a prescription

for Celexa at a strength higher than the FDA-recommended starting dose; (2) failing

to review Bobby’s medical records to assess his risks of taking Celexa given

Bobby’s family history, which includes a history showing that Bobby’s father

committed suicide; (3) failing to screen Bobby properly to evaluate the severity of

Bobby’s depression; (4) failing to warn Bobby about the adverse side-effects of

Celexa as related to the medication’s increased risk of suicide; and (5) failing to

advise Bobby on October 25 to discontinue the Celexa after Dr. Lee learned from

Bobby’s daughter that Bobby appeared to be confused and anxious after he started

taking Celexa. As to causation, Dr. Kosten’s report states the above acts and

omissions breached the standard of care that applied to treating patients like Bobby.

The report concludes the violations he identified in “the standards of care most likely

caused [Bobby’s] prescribed overdose of Celexa [and] his suicide . . . within a

reasonable degree of medical probability.”

In October 2020, the defendants moved to dismiss the plaintiffs’ suit. In their

joint motion, they argued that Dr. Dominguez’s and Dr. Kosten’s reports “are

woefully deficient” because they do not sufficiently explain how Dr. Lee’s alleged

acts and omissions caused Bobby’s death. The defendants also argued the two

5 reports of the plaintiffs’ experts did not link the experts’ respective conclusions to

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gardner v. U.S. Imaging, Inc.
274 S.W.3d 669 (Texas Supreme Court, 2008)
American Transitional Care Centers of Texas, Inc. v. Palacios
46 S.W.3d 873 (Texas Supreme Court, 2001)
Bowie Memorial Hospital v. Wright
79 S.W.3d 48 (Texas Supreme Court, 2002)
Christus Health Southeast Texas v. Broussard
306 S.W.3d 934 (Court of Appeals of Texas, 2010)
Downer v. Aquamarine Operators, Inc.
701 S.W.2d 238 (Texas Supreme Court, 1985)
RENAISSANCE HEALTHCARE SYSTEMS, INC. v. Swan
343 S.W.3d 571 (Court of Appeals of Texas, 2011)
Jelinek v. Casas
328 S.W.3d 526 (Texas Supreme Court, 2010)
Van Ness v. ETMC First Physicians
461 S.W.3d 140 (Texas Supreme Court, 2015)
Baty v. Olga Futrell, Crna, & Complete Anesthesia Care, P.C.
543 S.W.3d 689 (Texas Supreme Court, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steward-medical-group-dba-permian-premier-health-services-and-john-lee-v-texapp-2021.